Your browser doesn't support javascript.
loading
Cost of incorrect application of antithrombotic prophylaxis prior to invasive procedures.
Cuevas, Ma Victoria; Martínez-Sancho, Ignacio; Arribas, Jana; García-Díaz, Covadonga; Cuevas, Beatriz.
Afiliación
  • Cuevas MV; Hematology Service, University Hospital of Burgos, Avenida Islas Baleares 3, 09006, Burgos, Spain. mvcuevas@hubu.es.
  • Martínez-Sancho I; Primary Care Centre "Gamonal-Antigua", Av. de los Derechos Humanos.1, 09007, Burgos, Spain.
  • Arribas J; Health Economics Service, University Hospital of Burgos, Avenida Islas Baleares 3, 09006, Burgos, Spain.
  • García-Díaz C; Hematology Service, University Hospital of Burgos, Avenida Islas Baleares 3, 09006, Burgos, Spain.
  • Cuevas B; Hematology Service, University Hospital of Burgos, Avenida Islas Baleares 3, 09006, Burgos, Spain.
BMC Health Serv Res ; 19(1): 802, 2019 Nov 06.
Article en En | MEDLINE | ID: mdl-31694621
BACKGROUND: We analyze the cost of an incorrect application, by the haematologist, of bridging anticoagulation in patients with low-risk atrial fibrillation (AF) needing interruption of treatment prior to a scheduled invasive procedure. Although not recommended, bridging therapy is widely used, resulting in avoidable costs and increased workload. METHODS: Observational retrospective study. We recorded demographic and clinical data including age, sex, type of procedure, use of bridging therapy with low molecular weight heparin (LMWH), and haemorrhagic complications within 30 days of acenocoumarol withdrawal. RESULTS: Acenocoumarol was stopped in 161 patients, 97 (60%) were male and 64 (40%) female. Average age was 76,11 ± 8,45 years. Procedures included: minor surgical intervention 58 (36%), colonoscopy 61 (38%), gastroscopy 11 (7%), breast biopsy 4 (2.5%), prostate biopsy 4 (2.5%), infiltration 5 (3%), and other 18 (11%). All patients received bridging anticoagulation with LMWH (40 mg enoxaparin per day) 3 days before and 3 days after the procedure (6 doses). We used a total of 966 doses, at €4.5 per unit, resulted in €4347 of total cost. No complications occurred in 156 patients (97%). Haemorrhage was observed in 5 cases: 1 major haemorrhage needing 6 days of hospital stay and transfusion, and 4 minor haemorrhages (2 patients needed emergency attendance and 2 required hospital admission for 3 and 2 days, respectively). The cost of emergency care was €237.36, and the cost of hospital stay was €6860.81 (€623.71 per day, for 11 days). The total cost of the incorrect application of the protocol was €11,445.17. CONCLUSION: Guidelines about bridging anticoagulation in low risk AF patients undergoing scheduled invasive procedures were not followed. This practice increments the complications and supposes an increase in costs besides to an inadequate use of the human resources.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Heparina de Bajo-Peso-Molecular / Adhesión a Directriz / Anticoagulantes Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: BMC Health Serv Res Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2019 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Heparina de Bajo-Peso-Molecular / Adhesión a Directriz / Anticoagulantes Tipo de estudio: Guideline / Health_economic_evaluation / Observational_studies Límite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: BMC Health Serv Res Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2019 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido